CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 66 enrolled
Drug / intervention
Implantation with the commercially available Axium neurostimulatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02335502
NCT02335502N/ACompleted
CompareCT.gov

A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Intractable Pain

Abbott Medical Devices·observational·Posted Jan 9, 2015·Updated Feb 4, 2019

In Brief

An observational study evaluating Implantation with the commercially available Axium neurostimulator for Chronic Pain. Completed, enrolled 66 participants across 2 sites.

Detailed Summary

04-SMI-2012 is post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of chronic, intractable pain.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesNetherlands
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 9, 2015
Enrollment StartApr 1, 2012
Primary CompletionJun 1, 2015
Study CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 11.5 years ago

Interventions

Implantation with the commercially available Axium neurostimulatordevice